0

Journal Articles

in Lipids and Lipid Disorders
 81-100 of 267 Articles
Medical News & Perspectives |  May 21, 2008
Cholesterol Drug Controversy Continues
Mike Mitka
JAMA. 2008;299(19):2266. doi:10.1001/jama.299.19.2266.
Original Contribution |  May 21, 2008 FREE
Association Between Circulating Oxidized Low-Density Lipoprotein and Incidence of the Metabolic Syndrome
Paul Holvoet, PhD; Duk-Hee Lee, MD, PhD; Michael Steffes, MD, PhD; et al.
JAMA. 2008;299(19):2287-2293. doi:10.1001/jama.299.19.2287.
Original Contribution |  April 09, 2008 FREE
Omega-3 Free Fatty Acids for the Maintenance of Remission in Crohn Disease:  The EPIC Randomized Controlled Trials
Brian G. Feagan, MD; William J. Sandborn, MD; Ulrich Mittmann, MD; et al.
JAMA. 2008;299(14):1690-1697. doi:10.1001/jama.299.14.1690.
Original Contribution |  April 09, 2008 FREE
Effect of Lower Targets for Blood Pressure and LDL Cholesterol on Atherosclerosis in Diabetes:  The SANDS Randomized Trial
Barbara V. Howard, PhD; Mary J. Roman, MD; Richard B. Devereux, MD; et al.
JAMA. 2008;299(14):1678-1689. doi:10.1001/jama.299.14.1678.
Capitol Health Call |  April 09, 2008
Surrogate End Points Queried
Mike Mitka
JAMA. 2008;299(14):1657. doi:10.1001/jama.299.14.1657-a.
Commentary |  March 26, 2008
Surrogate End Points and FDA Approval:  A Tale of 2 Lipid-Altering Drugs
Bruce M. Psaty, MD, PhD; Thomas Lumley, PhD
JAMA. 2008;299(12):1474-1476. doi:10.1001/jama.299.12.1474.
Commentary |  February 27, 2008
Health Care as If Health Mattered
Thomas R. Frieden, MD, MPH; Farzad Mostashari, MD, MSc
JAMA. 2008;299(8):950-952. doi:10.1001/jama.299.8.950.
Commentary |  February 27, 2008
Critical Lessons From the ENHANCE Trial
Philip Greenland, MD; Donald Lloyd-Jones, MD, ScM
JAMA. 2008;299(8):953-955. doi:10.1001/jama.299.8.953.
Medical News & Perspectives |  February 27, 2008
Controversies Surround Heart Drug Study
Mike Mitka
JAMA. 2008;299(8):885-887. doi:10.1001/jama.299.8.885.
Capitol Health Call |  February 13, 2008
Celebrity Endorsements
Mike Mitka
JAMA. 2008;299(6):625. doi:10.1001/jama.299.6.625-a.
Medical News & Perspectives |  February 06, 2008
Therapies Aim to Boost “Good” Cholesterol
Mike Mitka
JAMA. 2008;299(5):509-510. doi:10.1001/jama.299.5.509.
Preliminary Communication |  February 06, 2008 FREE
Atherosclerotic Plaque Composition and Occurrence of Restenosis After Carotid Endarterectomy
Willem E. Hellings, MD; Frans L. Moll, MD, PhD; Jean-Paul P. M. De Vries, MD, PhD; et al.
JAMA. 2008;299(5):547-554. doi:10.1001/jama.299.5.547.
Health Agencies Update |  January 30, 2008
Lower Cholesterol Levels
JAMA. 2008;299(4):399. doi:10.1001/jama.2008.7.
Preliminary Communication |  September 26, 2007 FREE
Omega-3 Polyunsaturated Fatty Acid Intake and Islet Autoimmunity in Children at Increased Risk for Type 1 Diabetes
Jill M. Norris, MPH, PhD; Xiang Yin, MD, MS; Molly M. Lamb, BA; et al.
JAMA. 2007;298(12):1420-1428. doi:10.1001/jama.298.12.1420.
Review |  September 19, 2007 FREE
Association of Apolipoprotein E Genotypes With Lipid Levels and Coronary Risk
Anna M. Bennet, PhD; Emanuele Di Angelantonio, MD, MSc; Zheng Ye, PhD; et al.
JAMA. 2007;298(11):1300-1311. doi:10.1001/jama.298.11.1300.
Commentary |  September 12, 2007
Limitations of Applying Summary Results of Clinical Trials to Individual Patients:  The Need for Risk Stratification
David M. Kent, MD, MS; Rodney A. Hayward, MD
JAMA. 2007;298(10):1209-1212. doi:10.1001/jama.298.10.1209.
Lab Reports |  September 12, 2007
HDL Boosters
JAMA. 2007;298(10):1152. doi:10.1001/jama.298.10.1152-a.
Original Contribution |  August 15, 2007 FREE
Clinical Utility of Different Lipid Measures for Prediction of Coronary Heart Disease in Men and Women
Erik Ingelsson, MD, PhD; Ernst J. Schaefer, MD; John H. Contois, PhD; et al.
JAMA. 2007;298(7):776-785. doi:10.1001/jama.298.7.776.
Review |  August 15, 2007 FREE
High-Density Lipoprotein as a Therapeutic Target:  A Systematic Review
Inder M. Singh, MD, MS; Mehdi H. Shishehbor, DO, MPH; Benjamin J. Ansell, MD
JAMA. 2007;298(7):786-798. doi:10.1001/jama.298.7.786.
INCLUDES: CME
Editorial |  July 18, 2007
Triglycerides and Risk for Coronary Heart Disease
Patrick E. McBride, MD, MPH
JAMA. 2007;298(3):336-338. doi:10.1001/jama.298.3.336.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Internal Medicine
Viewpoint  |  May 6, 2013
Two New Drugs for Homozygous Familial Hypercholesterolemia:  Managing Benefits and Risks in a Rare Disorder
Robert J. Smith, MD; William R. Hiatt, MD
JAMA Internal Medicine
Research Letters  |  April 29, 2013
Limit to Benefits of Large Reductions in Low-Density Lipoprotein Cholesterol Levels: Use of Fractional Polynomials to Assess the Effect of Low-Density Lipoprotein Cholesterol Level Reduction in Metaregression of Large Statin Randomized Trials
Hisato Takagi, MD, PhD; Takuya Umemoto, MD, PhD; for the ALICE (All-Literature Investigation of Cardiovascular Evidence) Group
JAMA Internal Medicine
Invited Commentary  |  March 4, 2013
Getting to the Heart of HIV and Myocardial Infarction:  Comment on “HIV Infection and the Risk of Acute Myocardial Infarction”
Patrick W. G. Mallon, MB, BCh, PhD, FRACP, FRCPI
JAMA Internal Medicine
Research Letters  |  April 08, 2013
A National Survey of the Treatment of Hyperlipidemia in Primary Prevention
Michael E. Johansen, MD; Katherine J. Gold, MD, MSW, MS; Ananda Sen, PhD; et al.
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems